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SudanAbstract Cardiovascular disease is stabilizing in high-income countries and has
continued to rise in low-to-middle-income countries. Association of lipid profile with
lipoprotein lipase gene was studied in case and control subject. The family history,
hypertension, diabetes mellitus, smoking and alcohol consumption were the most
risk factors for early-onset of coronary heart disease (CHD). Sudanese patients
had significantly (P < 0.05) lower TC and LDL-C levels compared to controls. Allele
frequency of LPL D9N, N291S and S447X carrier genotype was 4.2%, 30.7% and
7.1%, respectively. We conclude that lipoprotein lipase polymorphism was not
associated with the incidence of CHD in Sudan.
ª 2015 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
LPL gene, Asp9Asn, Asn291Ser, and S447X are the
most important mutations described because of
their greater frequency and influence onsusceptibility to atherosclerosis [1]. The LPL D9N
and LPL N291S variants have been associated with
an adverse lipid profile, but the association with
cardiovascular disease has been less consistent
[2]. D9N and N291S have been associated in a
meta-analysis with an increase in triglycerides of
20% and 31%, respectively [3], and S447X was
Table 1 Associations of LPL genotypes with lipid profiles in Sudanese patient carriers of D9N, N291S and S447X genotypes compared with non-carrier controls.
Items D9N N291S S447X
Carrier Non-carrier P value Carrier Non-carrier P value Carrier Non-carrier P value
Genotype frequency n (%) n (%) n (%) n (%) n (%) n (%)
Case 3(0.05) 62(0.95) 22(0.30) 51(0.67) 8(0.15) 46(0.85)
Control 3(0.04) 75(0.96) 17(0.32) 37(0.69) 8(0.14) 51(0.86)
All 6(0.04) 137(0.96) 39(0.31) 88(0.69) 16(0.14) 97(0.86)
Allele frequency (%) (%) (%) (%) (%) (%)
Case 0.05 0.95 0.30 0.70 0.07 0.93
Control 0.04 0.96 0.32 0.69 0.07 0.93
All 0.04 0.96 0.31 0.69 0.07 0.93
Lipid Carrier (n = 2) Non-carrier (n = 49) P value Carrier (n = 14) Non-carrier (n = 26) P value Carrier (n = 5) Non-carrier (n = 36) P value
TC 133.50 ± 76.74 254.51 ± 15.50 0.129 173.43 ± 14.59 194.35 ± 10.70 0.255 173.80 ± 45.65 254.97 ± 17.01 0.104
TG 230.00 ± 115.19 300.47 ± 23.27 0.551 240.64 ± 36.34 229.19 ± 26.66 0.801 266.80 ± 71.65 283.19 ± 26.70 0.831
LDL 40.10 ± 69.89 146.50 ± 14.12 0.142 76.79 ± 12.77 105.05 ± 9.37 0.083 77.38 ± 39.53 152.19 ± 14.73 0.084
HDL 47.65 ± 26.13 48.83 ± 5.28 0.965 48.51 ± 4.13 41.65 ± 3.03 0.188 43.06 ± 18.55 47.39 ± 6.91 0.828
VLDL 46.00 ± 22.41 60.91 ± 4.53 0.517 48.13 ± 7.00 48.22 ± 5.14 0.992 53.36 ± 14.03 57.67 ± 5.23 0.775
The term carrier is used to refer to the sum of both homozygote and heterozygote for those polymorphisms. D9N G > A, N291S A > G, S447X C > G.
All data shown are means ± SE (mg/dl).
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increasing HDL-C [2]. The study aimed to deter-
mine risk factors and the association of lipid pro-
files with LPL gene in patients with coronary
artery disease and healthy Sudanese population.
2. Materials and Methods
This case control study was designed to study risk
factors, lipid profile in CHD patients and their
association with lipoprotein lipase gene in Sudan.
Informed consent was obtained from all
participants. Detailed demographic and risk factors
for CVD were collected using a structured
questionnaire.
Lipids were analyzed by MINDRAY BS-200 ana-
lyzer (MINDRAY, Shenzhen, China). Genomic DNA
was extracted from blood by kits and PCR-RFLP
was applied to detect D9N, N291 and S447X lipopro-
tein lipase genotype, using TaqI, RsaI and Mnl1
restriction enzyme, respectively. Statistical analy-
ses were performed using SPSS v.18.
3. Results and Discussion
Among the population 53.1% were male, 22% had
family history of CHD, 42.6% hypertension, 41.6%
diabetes, 18.2% smoking and 5.3% alcohol. The
low smoking and alcohol consumption may be due
to cultural denial of smoking and alcohol in our
community especially among females [4].
Patients show lower TC and LDL-C levels compared
to controls. African ancestry was significantly asso-
ciated with decreased TC, LDL and triglycerides [4].
Allele frequency of LPL D9N, N291S and S447X
carrier was 4.2%, 30.7% and 7.1%, respectively
(Table 1). The carrier of frequency of N291S was
ranging from 2% to 5% in different populations
[5]. While for S447X was 18% in patients with CAD
and 23% in the control [1]. In Tunisian population
the frequency of p.Asp9Asn variation was 10.37%
in CAD patients versus 3.66% in controls, and for
p.Ser447X was 8.8% in CAD patients versus 13.7%
in controls [2]. No significant (P < 0.05) association
in lipid profiles was found between carriers
(patient) and non-carriers (control) of D9N, N291Sand S447X genotype (Table 1). D9N and N291S vari-
ants were associated with higher plasma TG [3].
The S447X variant was associated with lower TG
and higher HDL, and lower risk of CHD [2]. In
healthy Tunisian population, heterozygote carriers
of the p.Asp9Asn substitution had a significant
increase of total cholesterol and a decrease of
HDL [2].4. Conclusion
Heart diseases are prevalent in Sudan and have
similar risk factors as elsewhere. The lipoprotein
lipase polymorphism was not associated with the
incidence of CHD in Sudan.Conflict of interests
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